| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.IMBIO.2015.02.002 |
| P698 | PubMed publication ID | 25708705 |
| P2093 | author name string | Yang Liu | |
| Xin Wang | |||
| Yan Li | |||
| Yuan Li | |||
| Jun Hu | |||
| Qing Feng | |||
| Chun-yan Guo | |||
| Zong-li Qi | |||
| Hai-fang Wang | |||
| Xin-jian Zhang | |||
| Xiang-rong Zhao | |||
| Xue-ping Huo | |||
| Peng-hua Zhao | |||
| Yi-gui Tang | |||
| P2860 | cites work | New world bats harbor diverse influenza A viruses | Q21090482 |
| Evolution and ecology of influenza A viruses | Q24634698 | ||
| Narcolepsy, 2009 A(H1N1) pandemic influenza, and pandemic influenza vaccinations: what is known and unknown about the neurological disorder, the role for autoimmunity, and vaccine adjuvants | Q27025757 | ||
| Molecular mimicry: frequency of reactivity of monoclonal antiviral antibodies with normal tissues | Q27486795 | ||
| A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins | Q27671165 | ||
| Productive infection of human skeletal muscle cells by pandemic and seasonal influenza A(H1N1) viruses. | Q30355533 | ||
| "Prepandemic" immunization for novel influenza viruses, "swine flu" vaccine, Guillain-Barré syndrome, and the detection of rare severe adverse events | Q30378494 | ||
| Response to a monovalent 2009 influenza A (H1N1) vaccine. | Q30380581 | ||
| Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebo-controlled trial. | Q30383576 | ||
| Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes | Q30397001 | ||
| Estimating background rates of Guillain-Barré Syndrome in Ontario in order to respond to safety concerns during pandemic H1N1/09 immunization campaign | Q30402750 | ||
| Serious adverse events following receipt of trivalent inactivated influenza vaccine in Korea, 2003-2010. | Q30405818 | ||
| Unusual muscular injury in an infant with severe H1N1 infection. | Q30418114 | ||
| Renal autoimmune epitope of group A streptococci specified by M protein tetrapeptide Ile-Arg-Leu-Arg | Q33582935 | ||
| Safety of influenza A (H1N1) 2009 monovalent vaccines - United States, October 1-November 24, 2009. | Q34088088 | ||
| Causality assessment of serious neurologic adverse events following 2009 H1N1 vaccination | Q36882923 | ||
| Immunological studies in ulcerative colitis. IV. Origin of autoantibodies | Q42833492 | ||
| Adverse events following influenza A (H1N1) 2009 monovalent vaccines reported to the Vaccine Adverse Event Reporting System, United States, October 1, 2009–January 31, 2010 | Q43152358 | ||
| Autoimmune response following influenza vaccination in patients with autoimmune inflammatory rheumatic disease | Q43172230 | ||
| In vitro and in vivo activity of MT201, a fully human monoclonal antibody for pancarcinoma treatment | Q74456186 | ||
| [Detection of autoimmune parameter of SARS patients] | Q80389995 | ||
| Thrombocytic thrombocytopenic purpura in a child with A/H1N1 influenza infection | Q83749692 | ||
| P433 | issue | 8 | |
| P304 | page(s) | 941-946 | |
| P577 | publication date | 2015-02-14 | |
| P1433 | published in | Immunobiology | Q15754985 |
| P1476 | title | Development and characterization of a panel of cross-reactive monoclonal antibodies generated using H1N1 influenza virus. | |
| P478 | volume | 220 |
Search more.